An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types Likely to Express Epidermal Growth Factor Receptor (EGFR).
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2015
At a glance
- Drugs Indium 111 ABT 806 (Primary)
- Indications Colorectal cancer; Head and neck cancer; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- 16 May 2013 Results will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.